Synthesis, structures and spectroscopic properties of new 1,2-bis[2-(4-methyl-7-acetylamino-1,8-naphthyridine)]ethylene ligand and its binuclear copper(I) complexes

The synthesis, characterization, spectroscopic properties of a new ligand 1,2-bis[2-(4-methyl-7-acetylamino-1,8-naphthyridine)]ethylene (L) and its two binuclear Cu(I) complexes containing triphenylphosphine (PPh₃) or bis(diphenylphosphino)methane (dppm), [Cu₂(L)(PPh₃)₄](BF₄)₂·2CH₂Cl₂ (1·2CH₂Cl₂) and [Cu₂(L)(dppm)₂](BF₄)₂·4H₂O (2·4H₂O) are reported. The structural investigation of these compounds based on X-ray crystal analysis shows that the copper(I) centers adopt different coordination geometries, O(N)CuP₂⁺ and NCuP₂⁺ for complexes 1 and 2, respectively. Upon irradiation of a degassed organic solution of L at 365 nm, photoinduced isomerization reaction and an intramolecular proton transfer of ligand L were detailed studied by absorption spectral changes. A spectroscopic investigation involving time-dependent density functional theory calculations allows assignment of the excited states that relate to emission and transient absorption spectra. The observed lower-energy absorption bands appearing in the region of 413 and 418 nm for 1 and 2 in dichloromethane are assigned to ligand-to-ligand charge transfer (LLCT, phosphine → napy) transition in nature. Compared with well-structured solid-state emission originating from ππ^∗ transition of ligand L, complexes 1 and 2 exhibit intense room-temperature solid-state emissions with λ_max at 586 and 620 nm, respectively. The energy and the shape of the emission bands are clearly different from that of the ligand, indicating the emissions come from different excited states.     

Solution NMR Conformational Analysis of the Potent Equilibrative Sensitive (ES) Nucleoside Transporter Inhibitor,S 6-(4-Nitrobenzyl)mercaptopurine Riboside (NBMPR)

Abstract

High resolution NMR analysis involving one-dimensional (1-D) ¹H and nuclear Overhauser (NOE) difference spectroscopy was applied to solutions of NBMPR in DMSO-d ₆. Coupling constants were obtained at different temperatures between 285 and 353 K, and used to analyze the rotamer preferences about the C-4′-C-5′ bond. The results revealed a rotamer distribution about the χ tortion angle that favors the high-anti range, a preponderance of the γ⁺ rotamer (at ～64 %) with respect to the γ torsion angle, and a higher population of the south (S) conformer, which was favored by as little as the 4 % to as much as 31 % over the north (N) conformer as calculated by the program PSEUROT 6.2. The high-anti glycosidic torsion orientation appears to be the major conformational difference between the solution structure of NBMPR determined in this study and the structure previously observed in the solid state.     

Oxidation of (hydroxyethyl)ferrocene by [2-pyridylmethylbis(2-ethylthioethyl)/amine]copper(II)

A kinetic study of the oxidation of (hydroxyethyl)ferrocene (HEF) by [2-pyridylmethylbis(2-ethyl-thioethyl)ainine]copper(II) (Cu(pmas)²⁺) is reported, with the objective of documenting the influence of the two thioether sulfur ligands on the electron transfer rate. Both reactants exhibit a first-order dependence at pH 6, I = 0.1 M(NaNO₃); k(25°C) = 1.3 × 10⁴M⁻¹sec⁻¹, ΔH3 = 10.1 kcal/mole, ΔS3 = −6 eu. The apparent Cu(pmas)^2+/+ self-exchange electron transfer rate constant calculated from this reaction on the basis of relative Marcus theory (4.7 × 10¹M⁻¹ sec⁻¹) agrees well with previous findings on ferrocytochrome c, Fe(CN)₆⁴⁻, and Ru(NH₃)₅py²⁺ oxidations. Spectrophotometric titrations of Cu(pmas)²⁺ and Cu(tmpa)²⁺ (tmpa = tris(2-pyridylmethyl)amine) with azide ion showed that both Cu(pmas)N₃)⁺ (K_f1 = 3.1 × 10³M⁻¹) and Cu(pmas)(N₃)₂ (K_f2 = 3.5 × 10¹M⁻¹) but Cu(tmpa)(N₃)⁺ (K_f = 6.6 × 10²M⁻¹) are formed up to 0.15 M N₃⁻ (25°C, pH 6, I = 0.2 M), suggesting that a thioether sulfur atom is displaced in the uptake of a second N₃⁻ ion by Cu(pmas)(N₃)⁺. The effect of thioether sulfur displacement by azide ion on the HEF-Cu(pmas)²⁺ reaction rate may be understood entirely through the tendency of N₃⁻ to shift the position of the redox equilibrium towards the reactant side, without invoking any special role for the sulfur ligand in promoting electron transfer reactivity.     

Synthesis,DNA Binding,and Oxidative Cleavage Studies of Fe(II) and Co(III) Complexes Containing Bioactive Ligands

The two complexes containing bioactive ligands of the type and [Fe(L)] (PF₆)₂ (1) (where L = [1-{[2-{[2-hydroxynaphthalen-1-yl)methylidine]amino}phenyl)imino] methyl}naphthalene-2-ol]) and [Co(L₁L₂)] (PF₆)₃ (2) (where L₁L₂ = mixed ligand of 2-seleno-4-methylquinoline and 1,10-phenanthroline in the ratio 1:2, respectively) were synthesized and structurally characterized. The DNA binding property of the complexes with calf thymus DNA has been investigated using absorption spectra, viscosity measurements, and thermal denaturation experiments. Intrinsic binding constant K_b has been estimated at room temperature. The absorption spectral studies indicate that the complexes intercalate between the base pairs of the CT-DNA tightly with intrinsic DNA binding constant of 2.8 × 10⁵ M^?1 for (1) and 4.8 × 10⁵ M^?1 for (2) in 5 mM Tris-HCl/50 mM NaCl buffer at pH 7.2, respectively. The oxidative cleavage activity of (1) and (2) were studied by using gel electrophoresis and the results show that complexes have potent nuclease activity.     

Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis,structure, and biological activity

The synthesis and characterization of three novel iridium(III) complexes and one rhodium(III) complex with 1-nitroso-2-naphthol (3) chelating as a 1,2-naphthoquinone-1-oximato ligand are described. The reaction of μ₂-halogenido-bridged dimers [(η⁵-C₅Me₅)IrX₂]₂ [X is Cl (1a), Br (1b), I (1c)] and [(η⁵-C₅Me₅)RhCl₂]₂ (2a) with 3 in CH₂Cl₂ yields the mononuclear complexes (η⁵-C₅Me₅)IrX(η²-C₁₀H₆N₂O) (4a, 4b, 4c) and (η⁵-C₅Me₅)RhCl(η²-C₁₀H₆N₂O) (5a). All compounds were characterized by their ¹H and ¹³C NMR, IR, and mass spectra, UV/vis spectra were recorded for 4a and 5a. The X-ray structure analyses revealed a pseudo-octahedral “piano-stool” configuration for the metals with bidentate coordination through oximato-N and naphthoquinone-O, forming a nearly planar five-membered metallacycle. The metal complexes 4a and 5a were evaluated in respect to their cytotoxicity and binding affinity toward double-stranded DNA. As determined in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, both exerted a much stronger cytotoxic effect toward HeLa and HL60 cancer cell lines than did cisplatin. The remarkable cytotoxicity of the compounds tested may be attributed to necrosis, rather than to apoptosis, as it is evidenced by the caspase-3/7 activation assay. No clear evidence was found for interaction with double-stranded DNA. The melting experiments showed no significant differences between thermodynamic parameters of intact DNA and DNA incubated with 3, 4a, or 5a, although these derivatives altered DNA recognition by the BamHI restriction enzyme. Therefore, the screened iridium and rhodium complexes 4a and 5a may still be interesting as potential anticancer drugs owing to their high cytotoxicity toward cancer cell lines, whereas they do not modify DNA in a way similar to that of cisplatin.     

Preparation, characterization and biological relevance of calcium(II)/diethylmalonate(-1,-2) complexes

Reactions of Ca(NO₃)₂·4H₂O and diethylmalonic acid (Et₂malH₂, its anions represent functional side-chain analogs of γ-carboxyglutamic acid residues which are implicated as essential Ca²⁺-binding ligands in a variety of proteins) in aqueous media have afforded compounds [Ca(Et₂malH)₂(H₂O)₃]_n (1) and [Ca(Et₂mal)(H₂O)]_n (2) at pH 4 and 8, respectively. The structure of 1 was determined by single-crystal, X-ray crystallography, which revealed an 1D coordination polymer. The diethylmalonate ligands exist in their monoanionic form and present two different coordination modes. The Ca^II ion is 7-coordinate with a pentagonal bipyramidal geometry. IR data are discussed in terms of the known (1) and proposed (2) structures of the complexes. The role of the carboxylate binding modes in determining the affinity of Ca²⁺ for the various metal binding sites in proteins containing the γ-carboxyglutamate residue is discussed in the light of our and previous results.     

Structural and reactivity studies on the ternary system guanine/methionine/trans-[PtCl2(NH3)L] (L=NH3, quinoline): implications for the mechanism of action of nonclassical trans-platinum antitumor complexes

 The present model study explores the chemistry of methionine complexes and ternary methionine-guanine adducts formed by trans-[PtCl₂(NH₃)₂] (1) and antitumor trans-[PtCl₂(NH₃)quinoline] (2) using 1D (¹H, ¹⁹⁵Pt) and 2D NMR spectroscopy. Compound 2 was substitution inert in reactions with N-acetyl-lmethionine [AcMet(H)]. Reactions of trans-[PtCl(NO₃)(NH₃)quinoline] (5) ("monoactivated" 2) with AcMetH in water and acetone at various stoichiometries point to Pt(II)-S binding that requires prior activation of the Pt-Cl bond by labile oxygen donors. Trans-[PtCl{AcMet(H)-S}(NH₃)quinoline](NO₃) (6) and trans-[Pt{AcMet(H)-S}₂(NH₃)quinoline](NO₃)₂ (7) were isolated from these mixtures. At high [Cl^–], AcMet(H) is displaced from 7, giving 6. Frozen stereodynamics in 6 at the thioether-S and slow rotation about the Pt-N_quinoline bond result in four spectroscopically distinguishable diastereomers. ¹H NMR spectra of 7 show faster exchange dynamics due to mutual trans-labilization of the sulfur donors. Substitution of chloride in trans-[PtCl(9-EtGua)(NH₃)L]NO₃ (L=NH₃, 3; L=quinoline, 4; 9-EtGua=9-ethylguanine, which mimics the first DNA binding step of 1 and 2) by methionine-sulfur proceeded ca. 2.5 times slower for the quinoline compound. Both reactions, in turn, proved to be ca. 4 times faster than binding of a second nucleobase under analogous conditions. From the resulting mixtures the ternary adducts trans-[Pt(AcMet-S)(9-EtGua-N7)(NH₃)L](NO₃, Cl) (L=NH₃, 8; L=quinoline, 9) were isolated. A species analogous to 9 formed in a rapid reaction between 6 and 5′-guanosine monophosphate (5′-GMP). From NMR data an AMBER-based solution structure of the resulting adduct, trans-[Pt(AcMet-S)(5′-GMP-N7)(NH₃)quinoline] (10), was derived. The unusual reactivity along the N7-Pt-S axis in 8–10 resulted in partial release of both 9-EtGua and AcMet at high [Cl^–]. Possible consequences of the kinetic and structural effects (e.g., trans effect of sulfur, steric demand of quinoline) observed in these systems with respect to the (trans)formation of potential biological cross-links are discussed. Received: 25 May 1998 / Accepted: 6 August 1998     

Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes

Polynuclear platinum(II) complexes represent a class of potential anticancer agents that have shown promising pharmacological properties in preclinical studies. The nature of cellular responses induced by these complexes, however, is poorly understood. In this research, the cellular responses of human ovarian cancer COC1 cells to dinuclear platinum(II) complexes {[cis-Pt(NH₃)₂Cl]₂L¹}(NO₃)₂ (1) and {[cis-Pt(NH₃)₂Cl]₂L²}(NO₃)₂ (2) (L¹ = α,α′-diamino-p-xylene, L² = 4,4′-methylenedianiline) has been studied using cisplatin as a reference. The effect of platinum complexes on the proliferation, death mode, mitochondrial membrane potential, and cell cycle progression has been examined by MTT assay and flow cytometry. The activation of cell cycle checkpoint kinases (CHK1/2), extracellular signal-regulated kinases (ERK1/2), and p38 mitogen-activated protein kinase (p38 MAPK) of the cells by the complexes has also been analyzed using phospho-specific flow cytometry. Complex 1 is more cytotoxic than complex 2 and cisplatin at most concentrations; complex 2 and cisplatin are comparably cytotoxic. These complexes kill the cells through an apoptotic or apoptosis-like pathway characterized by exposure of phosphatidylserine and dissipation of mitochondrial membrane potential. Complex 1 shows the strongest inductive effect on the morphological changes of the cells, followed by cisplatin and complex 2. Complexes 1 and 2 arrest the cell cycle in G2 or M phase, while cisplatin arrests the cell cycle in S phase. The influence of these complexes on CHK1/2, ERK1/2, and p38 MAPK varies with the dose of the drugs or reaction time. Activation of phospho-ERK1/2 and phospho-p38 MAPK by these complexes is closely related to the cytostatic activity. The results demonstrate that dinuclear platinum(II) complexes can induce some cellular responses different from those caused by cisplatin.     

Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione

trans -[PtCl₄(NH₃)(thiazole)] (1), trans-[PtCl₄(cha)(NH₃)] (2), cis-[PtCl₄(cha)(NH₃)] (3) (cha =cyclohexylamine), and cis-[PtCl₄(NH₃)₂] (4) has been investigatedat 25 °C in a 1.0 M aqueous medium at pH 2.0–5.0 (1) and 4.5–6.8 (2–4) using stopped-flow spectrophotometry. The redox reactions follow the second-order rate law , where k is a pH-dependent rate constant and [GSH]_tot the total concentration of glutathione. The reduction takes place via parallel reactions between the platinum(IV) complexes and the various protolytic species of glutathione. The pH dependence of the redox kinetics is ascribed to displacement of these protolytic equilibria. The thiolate species GS⁻ is the major reductant under the reaction conditions used. The second-order rate constants for reduction of compounds 1–4 by GS⁻ are (1.43±0.01)×10⁷, (3.86±0.03)×10⁶, (1.83±0.01)×10⁶, and (1.18±0.01)×10⁶M⁻¹s⁻¹, respectively. Rate constants for reduction of 1 by the protonated species GSH are more than five orders of magnitude smaller. The mechanism for the reductive elimination reactions of the Pt(IV) compounds is proposed to involve an attack by glutathione on one of the mutually trans coordinated chloride ligands, leading to two-electron transfer via a chloride-bridged activated complex. The kinetics results together with literature data indicate that platinum(IV) complexes with a trans Cl-Pt-Cl axis are reduced rapidly by glutathione as well as by ascorbate. In agreement with this observation, cytotoxicity profiles for such complexes are very similar to those for the corresponding platinum(II) product complexes. The rapid reduction within 1 s of the platinum(IV) compounds with a trans Cl-Pt-Cl axis to their platinum(II) analogs does not seem to support the strategy of using kinetic inertness as a parameter to increase anticancer activity, at least for this class of compounds. Received: 8 December 1999 / Accepted: 15 February 2000     

Definitive Solution Structures for the 6-Formylated Versions of 1-(βD-Ribofuranosyl)-, 1-(2′-Deoxy-β-D-Ribofuranosyl)-, and 1-β-D-Arabinofuranosyluracil,and of Thymidine

Abstract

ROESY and NOESY NMR spectroscopic analyses of the ribofuranosyl (1a), 2′-deoxyribofuranosyl (1b), and arabinofuranosyl (1c) derivatives of 6-formyluracil in (CD₃)₂SO and D₂O solutions have established that each exclusive 7,05′-cyclic hemiacetal diastereomer of 1a,b and the major 7,O2′-cyclic hemiacetal diastereomer of 1c possess the 7R configuration. In addition, (7R)-1c has been shown to be thermodynamically more stable than (7S)-1c, contrary to our previous indication. A new, higher yielding synthetic route to 1a has been developed, 1b has been obtained for the first time in crystalline form, the route to 1c has been modified to better accommodate large scale preparations, and a new, fourth member of this class, 6-formylthymidine (1d), has been synthesized and its solution structures in (CD₃)₂SO, D₂O, and CD₃OD have been determined. Antitumor and antiviral evaluations of 1a-c have revealed no significant levels of activity.     

Phenoxyl-copper(II) complexes: models for the active site of galactose oxidase

 The reaction of the macrocycles 1,4,7-tris (3,5-di-tert-butyl-2-hydroxy-benzyl)-1,4,7-triazacyclononane, L¹H₃, or 1,4,7-tris(3-tert-butyl-5-methoxy-2-hydroxy-benzyl)-1,4,7-triazacyclononane, L²H₃, with Cu(ClO₄)₂·6H₂O in methanol (in the presence of Et₃N) affords the green complexes [Cu^II(L¹H)] (1), [Cu^II(L²H)]·CH₃OH (2) and (in the presence of HClO₄) [Cu^II(L¹H₂)](ClO₄) (3) and [Cu^II(L²H₂)] (ClO₄) (4). The Cu^II ions in these complexes are five-coordinate (square-base pyramidal), and each contains a dangling, uncoordinated pendent arm (phenol). Complexes 1 and 2 contain two equatorially coordinated phenolato ligands, whereas in 3 and 4 one of these is protonated, affording a coordinated phenol. Electrochemically, these complexes can be oxidized by one electron, generating the phenoxyl-copper(II) species [Cu^II(L¹H)]^+ ·, [Cu(L²H)]^+ ·, [Cu^II(L¹H₂)]^2+ ·, and [Cu^II(L²H₂)]^2+ ·, all of which are EPR-silent. These species are excellent models for the active form of the enzyme galactose oxidase (GO). Their spectroscopic features (UV-VIS, resonance Raman) are very similar to those reported for GO and unambiguously show that the complexes are phenoxyl-copper(II) rather than phenolato-copper(III) species. Received: 10 February 1997 / Accepted: 7 April 1997     

Ordering selected Zn(II), Cu(II), Pd(II) and Co(III) complex compounds: their separately and combinedly antibacterial therapy and DNA-binding studies

Abstract

In this study, four Co(III)-, Cu(II)-, Zn(II)- and Pd(II)-based potent antibacterial complexes of formula K₃[Co(ox)₃]·3H₂O (I), [Cu(phen)₂Cl]Cl·6.5H₂O (II), [Zn(phen)₃]Cl₂ (III) and [Pd(phen)₂](NO₃)₂ (IV) (where ox is oxalato and phen is 1,10-phenanthroline) were synthesized. They were characterized by elemental analysis, molar conductivity measurements, UV–vis, Fourier transform infrared (FT-IR) and proton nuclear magnetic resonance (¹H-NMR) techniques. These metal complexes were ordered in three combination series of I+II, I+II+III and I+II+III+IV. Antibacterial screening for each metal complex and their combinations against Gram-positive and Gram-negative bacteria revealed that all compounds were more potent antibacterial agents against the Gram-negative than those of the Gram-positive bacteria. The four metal complexes showed antibacterial activity in the order I > II > III > IV, and the activity of their combinations followed the order of I+II+III+IV > I+II+III > I+II. The DNA-binding properties of complex (I) and its three combinations were studied using electronic absorption and fluorescence (ethidium bromide displacement assay) spectroscopy. The results obtained indicated that all series interact effectively with calf thymus DNA (CT-DNA). The binding constant (K_b), the number of binding sites (n) and the Stern–Volmer constant (K_sv) were obtained based on the results of fluorescence measurements. The calculated thermodynamic parameters supported that hydrogen bonding and van der Waals forces play a major role in the association of each series of metal complexes with CT-DNA and follow the above-binding affinity order for the series.

Communicated by Ramaswamy H. Sarma     

Reactivity of an extremenly sterically crowded monofunctional Pt complex, [Pt(1-MeC-N3)3(H2O)]2+ (1-MeC=1-methylcytosine), toward model nucleobases and selectivity toward guanine in single- and double-stranded deoxyoligonucleotides

 Reactions of [Pt(1-MeC-N3)₃Cl]NO₃ (1-MeC-N3=1-methylcytosine, bound to Pt via N3) and the respective aqua species [Pt(1-MeC-N3)₃(H₂O)]²⁺ with the model nucleobases 9-ethylguanine (9-EtGH), 9-methyladenine (9-MeA), single-stranded 5′d(T₃GT₃), and double-stranded [5′d(GAGA₂GCT₂CTC)]₂ have been studied in solution by means of ¹H NMR spectroscopy, HPLC, and electrospray ionization mass spectrometry. Reactions are generally slow, in particular with the chloro species, and guanine is the only reactive base in the oligonucleotides. However, unlike (dien)Pt^II, which binds randomly to the guanines in the ds dodecamer, (1-MeC-N3)₃Pt^II binds selectively to the terminal guanine only, probably because base fraying takes place at the duplex ends. The X-ray crystal structures of [Pt(1-MeC-N3)₃(9-EtG-N7)]ClO₄·8H₂O (1b) and of [Pt(1-MeC-N3)₃(9-MeA-N7)](ClO₄)₂·0.5H₂O as well as NMR spectroscopic studies of [Pt(1-MeC-N3)₃(9-EtGH-N7)] (NO₃)₂·H₂O (1a) are reported. The tetrakis(nucleobase) complexes adopt a head-tail-head orientation of the three 1-MeC bases and an orientation of the fourth base (purine) that permits a maximum of intracomplex H bonds between exocyclic groups. As far as the guanine adduct (1a, 1b) is concerned, relative orientations of the four bases are identical in the model and in the oligonucleotide adduct. Received: 19 June 1998 / Accepted: 1 October 1998     

Crystal structure of Ce(IV)/dipicolinate complex as catalyst for DNA hydrolysis

The structures of Ce⁴⁺ complexes that are active for DNA hydrolysis were determined for the first time by X-ray crystallography. The crystals were prepared from a 1:2 mixture of Ce(NH₄)₂(NO₃)₆ and dipicolinic acid (2,6-pyridinedicarboxylic acid). Depending on the recrystallization conditions, three types of crystals were obtained. Some of the Ce⁴⁺ ions in these complexes have enough coordinated water molecules that can directly and indirectly participate in the catalysis. The distances between the Ce⁴⁺ and the dipicolinate ligand are considerably shorter than those in the corresponding La³⁺ and Ce³⁺ complexes. On the other hand, the distances between the Ce⁴⁺ and its coordinated water are similar to those for the La³⁺ and Ce³⁺ complexes. In a proposed mechanism of DNA hydrolysis, the scissile phosphodiester linkage is notably activated by coordination to Ce⁴⁺ and attacked by the Ce⁴⁺-bound hydroxide. The process is further assisted by acid catalysis of Ce⁴⁺-bound water. Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorized users.     

Synthesis,inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease

Two mononuclear copper(II) complexes, [Cu(C₁₅H₁₆NO₂)₂] (1) and [Cu(C₆H₉N₂O₄)₂·3H₂O] (2·3H₂O), were synthesised and structurally characterised by single-crystal X-ray analysis. The copper(II) atom adopts a square-planar environment in complex 1, while the geometry in 2·3H₂O could be described as the distorted square pyramidal. Complexes 1 and 2·3H₂O were evaluated for their inhibitory activities against Helicobacter pylori (H. pylori) urease in vitro. They both were found to have strong inhibitory activities against H. pylori urease comparable to that of acetohydroxamic acid (AHA). A docking simulation was performed to position 2 into the H. pylori urease active site to determine the probable binding conformation.     

Aliphatic pincer-type POCOP ligands and their complexation behaviour with iridium: Crystal structure of an iridium(III) phosphinite complex

Reaction of 2 equivalents of 1,3-bis-(di-tert-butylphosphinito)-2-methyl-propane (1a) with [Ir(COD)Cl]₂ affords the first aliphatic diphosphinite PCP pincer complex with iridium, Ir(H){(t-Bu₂POCH₂)₂C(Me)}Cl (2). The poor yield of 2 is partly explained by the formation of a di-nuclear byproduct [IrCl(COD)]₂(μ₂-{(t-Bu₂POCH₂)₂CH(Me)}) (3). Reaction of 1,3-bis-(di-iso-propylphosphinito)-2-methyl-propane (1b) under the same condition does not give any cyclometallation, and reaction with IrCl₃·H₂O in DMF leads to complete decomposition of the pincer ligand under the formation of Ir(H)(i-Pr₂P(OH))₃(CO) (4), underpinning the comparatively low thermal stability of aliphatic phosphinite pincer systems.     

Bipyrimidine-bridged rhenium(I)/rhenium(I) and ruthenium(II)/rhenium(I) complexes. Synthesis,electronic absorption and emission spectra

The binuclear complexes [Cl(OC)₃Re^I(bipym)Re^I(CO)₃Cl] (bipym=2,2′-bipyrimidine), [(bipy)₂Ru^II(bipym)Re^I(CO)₃Cl](PF₆)₂ (bipy=2,2′-bipyridine) and their mononuclear component [Re(bipym)(CO)₃Cl] were prepared. The electronic absorption spectra of these complexes display low-energy Re(I) →π*(bipym) and Ru(II)→π*(bipym) charge transfer (CT) bands. While [Re(bipym)(CO)₃Cl] shows a strong emission from its lowest CT state, the dimer [Cl(OC)₃Re(bipym)Re(CO)₃Cl] is not luminescent. The cation [(bipy)₂Ru(bipym)Re(CO)₃Cl]²⁺ emits from the lowest-energy Ru→bipym CT state. The emission behavior of the binuclear complexes is described in terms of intramolecular excited state electron or energy transfer.     

Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation,DNA/albumin binding,biological profile analysis,and molecular docking study

Two novel copper (II) substituted thiosemicarbazone Schiff base complexes [Cu(L₁)(µ-SCN)]_n(NO₃)₂ (1) and [Cu₂(µ-SCN)(SCN)(L₂)₂](NO₃) (2) have been synthesized by condensing substituted thiosemicarbazides like 4-methyl-3-thiosemicarbazide or 4-ethyl-3-thiosemicarbazide with 2-acetylpyridine. Both the metal complexes 1 and 2 are characterized using different spectroscopic techniques like IR, UV-Vis, ESR spectroscopy followed by elemental analysis, cyclic voltammetric measurement and single crystal X-ray structure analysis. X-ray crystal structure analysis reveal that complex 1 is polymeric while complex 2 is dimeric in nature. The coordination geometry around Cu(II) are square pyramidal in which thiosemicarbazone Schiff base ligand coordinate to the central Cu(II) atom in tridentate fashion. The prominent interaction patterns of 1 and 2 with CT-DNA were examined by employing electronic absorption and emission spectral titrations, cyclic voltammetry and viscosity measurements. All the results show that CT-DNA binds with both copper (II) complexes 1 and 2. Furthermore, protein binding ability in vitro of complexes 1 and 2 with both BSA and HSA were carried out using multispectroscopic techniques and a static quenching pattern was observed in both cases. Molecular docking study was employed to ascertain the exact mechanism of action of 1 and 2 with DNA and protein molecules (BSA and HSA). In vitro cytotoxicity activity of complexes 1 and 2 toward AGS and A549 was evaluated using MTT assay which demonstrates that both complexes 1 and 2 have superior prospectus to act as anticancer agents.

Communicated by Ramaswamy H. Sarma     

Supramolecular diversity and magnetic properties of novel heterometallic Cu(II)/Cr(III) complexes prepared from copper powder, Reineckes salt and ethylenediamine

Three novel heterometallic complexes [Cu(en)₂Cr(NCS)₄(NH₃)₂][Cr(NCS)₄(NH₃)₂] · 6dmf (1), [Cu(en)₂Cr(NCS)₄(NH₃)₂](OAc) (2) and [{Cu(en)₂}₃{Cr(NCS)₄(NH₃)₂}₂(NCS)₂](NCS)₂ (3) have been synthesized in a one-pot reaction from copper powder, Reineckes salt, NH₄X [X⁻ = OAc⁻ (2), NCS⁻ (3)] in a dmf (1) or CH₃CN (2, 3) solution of ethylenediamine (en). X-ray studies showed that 1 and 2 consist of cationic polymeric chains, formed by and building blocks that bridged through thiocyanate anions. In both complexes, distinct hydrogen bonds are present and serve to increase the dimensionality of the compound from one to two (in 1) or three (in 2). The main structural feature of 3 is the pentanuclear Cu₃Cr₂ cation which is H-bonded with uncoordinated thiocyanate groups generating a 3D supramolecular assembly. The shortest Cu?Cr distances are 5.840(1) Å for 1, 5.856(1) and 6.018(3) Å for 2 and 6.009(9) and 6.465(9) Å for 3. Compounds 1 and 2 are essentially paramagnets whereas compound 3 shows a weak antiferromagnetic coupling. The magnetic properties are simulated and discussed in terms of the structural features.     

Synthesis,characterization, cytotoxicity,and DNA binding of some new platinum(II) and platinum(IV) complexes with benzimidazole ligands

In this study, two Pt(II) and three Pt(IV) complexes with the structures of [PtL₂Cl₂] (1), [PtL₂I₂] (2), [PtL₂Cl₂(OH)₂] (3), [PtL₂Cl₂(OCOCH₃)₂] (4), and [PtL₂Cl₄] (5) (L = benzimidazole as carrier ligand) were synthesized and evaluated for their in vitro antiproliferative activities against the human MCF-7, HeLa, and HEp-2 cancer cell lines. The influence of compounds 1–5 on the tertiary structure of DNA was determined by their ability to modify the electrophoretic mobility of the form I and II bands of pBR322 plasmid DNA. The inhibition of BamH1 restriction enzyme activity of compounds 1–5 was also determined. In general, it was found that compounds 1–5 were less active than cisplatin and carboplatin against MCF-7 and HeLa cell lines (except for 1, which was found to be more active than carboplatin against the MCF-7 cell line). Compounds 1 and 3 were found to be significantly more active than cisplatin and carboplatin against the HEp-2 cell line.